首页 > 最新文献

Journal of the Saudi Heart Association最新文献

英文 中文
Underlying Coronary Microvascular Disease May Lead to Underestimation of Global Longitudinal Strain Differences. 潜在的冠状动脉微血管疾病可能导致对全球纵向应变差异的低估。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1272
Neelesh Gupta, Mohammed Elkhazendar, Rajeev Gupta
{"title":"Underlying Coronary Microvascular Disease May Lead to Underestimation of Global Longitudinal Strain Differences.","authors":"Neelesh Gupta, Mohammed Elkhazendar, Rajeev Gupta","doi":"10.37616/2212-5043.1272","DOIUrl":"https://doi.org/10.37616/2212-5043.1272","url":null,"abstract":"","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"293"},"PeriodicalIF":0.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/ec/sha-33-4-293.PMC8754449.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications After Surgical Repair of Congenital Heart Disease in Infants. An Experience From Tertiary Care Center. 婴儿先天性心脏病手术修复后的并发症。三级保健中心的经验。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1267
Farrukh Javed, Nabil Abdulrahman Aleysae, Abdulmajid Yahya Al-Mahbosh, Amal Ali Zubani, Ali Mohammed Atash, Hanan Bin Salem, Mohamed Abdallah, Omaima Alkhatib, Ashraf Abu-Adas, Maymoona Abdelmouz Hrays, Nawal Ali Alqarni, Alla Felemban, Saad Abdullah Alsaedi, Ahmed Abdullah Jamjoom

Objectives: This study aimed to describe the incidence and spectrum of postoperative complications in infants who underwent their first cardiac surgery for the repair of congenital heart diseases.

Methods: This is a single-center retrospective study. Data of infants admitted to King Faisal Specialist Hospital & Research Center; Jeddah; Saudi Arabia, from January 2015 to December 2019 who underwent the first cardiac procedure for congenital heart disease at an age of less than 3 months, were analyzed. The primary outcome is the prevalence and spectrum of postoperative complications during hospitalization. Data were analyzed by using descriptive and analytical statistics using SAS software version 9.4.

Results: Data of 130 procedures were analyzed. The most frequent procedure performed was the Norwood procedure (31.5%), aortic coarctation repair (13.8%), arterial switch operation (13%), and Blalock-Taussig and central shunts (10%). The overall postprocedural complications were reported in 96 (73.8%) of the procedures. The most frequent complications were prolonged postoperative mechanical ventilation (27%), pleural effusion (21%), excessive bleeding (19%), cardiac arrest (18%), and systemic infections (18%).

Conclusion: Cardiac surgery for congenital heart disease in young infants has a substantial risk for postoperative complications. The high incidence of these complications in these cases makes necessary attention to prove the outcomes in the cardiac centers.

目的:本研究旨在描述首次接受先天性心脏病修复心脏手术的婴儿术后并发症的发生率和范围。方法:这是一项单中心回顾性研究。费萨尔国王专科医院和研究中心收治的婴儿数据;吉达;对沙特阿拉伯2015年1月至2019年12月期间因先天性心脏病接受首次心脏手术的年龄不足3个月的患者进行了分析。主要结果是住院期间术后并发症的发生率和范围。采用SAS 9.4版软件对数据进行描述性统计和分析性统计。结果:对130例手术资料进行分析。最常见的手术是Norwood手术(31.5%)、主动脉缩窄修复(13.8%)、动脉转换手术(13%)、Blalock-Taussig和中心分流术(10%)。96例(73.8%)出现术后并发症。最常见的并发症是术后机械通气时间延长(27%)、胸腔积液(21%)、大出血(19%)、心脏骤停(18%)和全身感染(18%)。结论:婴幼儿先天性心脏病的心脏手术有很大的术后并发症风险。这些病例的并发症发生率高,因此有必要注意在心脏中心证实预后。
{"title":"Complications After Surgical Repair of Congenital Heart Disease in Infants. An Experience From Tertiary Care Center.","authors":"Farrukh Javed,&nbsp;Nabil Abdulrahman Aleysae,&nbsp;Abdulmajid Yahya Al-Mahbosh,&nbsp;Amal Ali Zubani,&nbsp;Ali Mohammed Atash,&nbsp;Hanan Bin Salem,&nbsp;Mohamed Abdallah,&nbsp;Omaima Alkhatib,&nbsp;Ashraf Abu-Adas,&nbsp;Maymoona Abdelmouz Hrays,&nbsp;Nawal Ali Alqarni,&nbsp;Alla Felemban,&nbsp;Saad Abdullah Alsaedi,&nbsp;Ahmed Abdullah Jamjoom","doi":"10.37616/2212-5043.1267","DOIUrl":"https://doi.org/10.37616/2212-5043.1267","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to describe the incidence and spectrum of postoperative complications in infants who underwent their first cardiac surgery for the repair of congenital heart diseases.</p><p><strong>Methods: </strong>This is a single-center retrospective study. Data of infants admitted to King Faisal Specialist Hospital & Research Center; Jeddah; Saudi Arabia, from January 2015 to December 2019 who underwent the first cardiac procedure for congenital heart disease at an age of less than 3 months, were analyzed. The primary outcome is the prevalence and spectrum of postoperative complications during hospitalization. Data were analyzed by using descriptive and analytical statistics using SAS software version 9.4.</p><p><strong>Results: </strong>Data of 130 procedures were analyzed. The most frequent procedure performed was the Norwood procedure (31.5%), aortic coarctation repair (13.8%), arterial switch operation (13%), and Blalock-Taussig and central shunts (10%). The overall postprocedural complications were reported in 96 (73.8%) of the procedures. The most frequent complications were prolonged postoperative mechanical ventilation (27%), pleural effusion (21%), excessive bleeding (19%), cardiac arrest (18%), and systemic infections (18%).</p><p><strong>Conclusion: </strong>Cardiac surgery for congenital heart disease in young infants has a substantial risk for postoperative complications. The high incidence of these complications in these cases makes necessary attention to prove the outcomes in the cardiac centers.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"271-278"},"PeriodicalIF":0.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0a/2c/sha-33-4-271.PMC8754435.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Predictors of 6-month Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome: A Study in Pakistani Population. 非st段抬高急性冠脉综合征患者6个月死亡率的预测因素:巴基斯坦人群研究
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1269
Dileep Kumar, Tahir Saghir, Rajesh Kumar, Jawaid Akbar Sial, Kamran Ahmed Khan, Jehangir Ali Shah, Musa Karim, Abdul Mueed, Reeta Bai, Hitesh Kumar, Sajjad Ali, Rekha Kumari

Objectives: For Southern Asian countries like Pakistan, there is inadequate evidence of risk factors associated with mortality in patients suffering from acute coronary syndrome (ACS), especially non-ST elevation ACS (NSTE-ACS) cases. Therefore, aim of this study was to evaluate predictors of 6-months mortality of patients presenting with NSTE-ACS.

Methods: For this prospective observational study we recruited adult patients diagnosed with NSTE-ACS at a tertiary cardiac center. All he patients were followed-up after six months and survival status was recorded. Logistic regression analysis was performed for six-month mortality and odds ratio (OR) and 95% confidence interval (CI) were reported.

Results: Six-month follow-up was successful for 280 patients. On univariate analysis age >65 years, increased heart rate, cardiac arrest at presentation, Killip class II-IV at presentation, and diabetes were found to be associated with increased risk of 6-months mortality with OR [95% CI] of 4.27 [1.9-9.58], 1.25 [1.1-1.41], 139.44 [16.9-1150.78], 68.45 [7.88-594.41], and 2.35 [1.06-5.22] respectively. On multivariable analysis Killip class II-IV at presentation, thrombolysis in myocardial infarction (TIMI) score of >4, and global registry of acute coronary events (GRACE) score ≥150 were found to be independent predictors of mortality after six months of NSTE-ACS with adjusted OR of 32.93 [2.65-408.8], 3.42 [1.35-8.66], and 8.43 [3.33-21.38] respectively.

Conclusions: For patients with NSTE-ACS, our study showed seven clinical parameters to be associated with an increased risk of 6-month mortality. These included increasing age, increased heart rate, cardiac arrest at presentation, Killip class II-IV, diabetes, TIMI score of >4 and GRACE score of >150. Thereby aiding clinicians to apply strategic and precise interventions in monitoring these patients accordingly.

目的:在南亚国家,如巴基斯坦,没有足够的证据表明急性冠脉综合征(ACS)患者的死亡率与危险因素相关,特别是非st段抬高ACS (NSTE-ACS)病例。因此,本研究的目的是评估NSTE-ACS患者6个月死亡率的预测因素。方法:在这项前瞻性观察性研究中,我们招募了在三级心脏中心诊断为NSTE-ACS的成年患者。随访6个月,记录患者的生存状况。对6个月死亡率进行Logistic回归分析,并报告优势比(OR)和95%可信区间(CI)。结果:280例患者6个月随访成功。在单因素分析中,年龄>65岁、心率加快、首发时心脏骤停、首发时Killip II-IV级和糖尿病与6个月死亡风险增加相关,OR [95% CI]分别为4.27[1.9-9.58]、1.25[1.1-1.41]、139.44[16.9-1150.78]、68.45[7.88-594.41]和2.35[1.06-5.22]。多变量分析Killip class II-IV时,心肌梗死溶栓(TIMI)评分>4,急性冠状动脉事件全球登记(GRACE)评分≥150是NSTE-ACS 6个月后死亡率的独立预测因子,调整后OR分别为32.93[2.65-408.8]、3.42[1.35-8.66]和8.43[3.33-21.38]。结论:对于NSTE-ACS患者,我们的研究显示7个临床参数与6个月死亡风险增加相关。这些因素包括年龄增加、心率增加、出现时心脏骤停、Killip II-IV级、糖尿病、TIMI评分>4和GRACE评分>150。从而帮助临床医生应用战略和精确的干预措施来监测这些患者。
{"title":"Predictors of 6-month Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome: A Study in Pakistani Population.","authors":"Dileep Kumar,&nbsp;Tahir Saghir,&nbsp;Rajesh Kumar,&nbsp;Jawaid Akbar Sial,&nbsp;Kamran Ahmed Khan,&nbsp;Jehangir Ali Shah,&nbsp;Musa Karim,&nbsp;Abdul Mueed,&nbsp;Reeta Bai,&nbsp;Hitesh Kumar,&nbsp;Sajjad Ali,&nbsp;Rekha Kumari","doi":"10.37616/2212-5043.1269","DOIUrl":"https://doi.org/10.37616/2212-5043.1269","url":null,"abstract":"<p><strong>Objectives: </strong>For Southern Asian countries like Pakistan, there is inadequate evidence of risk factors associated with mortality in patients suffering from acute coronary syndrome (ACS), especially non-ST elevation ACS (NSTE-ACS) cases. Therefore, aim of this study was to evaluate predictors of 6-months mortality of patients presenting with NSTE-ACS.</p><p><strong>Methods: </strong>For this prospective observational study we recruited adult patients diagnosed with NSTE-ACS at a tertiary cardiac center. All he patients were followed-up after six months and survival status was recorded. Logistic regression analysis was performed for six-month mortality and odds ratio (OR) and 95% confidence interval (CI) were reported.</p><p><strong>Results: </strong>Six-month follow-up was successful for 280 patients. On univariate analysis age >65 years, increased heart rate, cardiac arrest at presentation, Killip class II-IV at presentation, and diabetes were found to be associated with increased risk of 6-months mortality with OR [95% CI] of 4.27 [1.9-9.58], 1.25 [1.1-1.41], 139.44 [16.9-1150.78], 68.45 [7.88-594.41], and 2.35 [1.06-5.22] respectively. On multivariable analysis Killip class II-IV at presentation, thrombolysis in myocardial infarction (TIMI) score of >4, and global registry of acute coronary events (GRACE) score ≥150 were found to be independent predictors of mortality after six months of NSTE-ACS with adjusted OR of 32.93 [2.65-408.8], 3.42 [1.35-8.66], and 8.43 [3.33-21.38] respectively.</p><p><strong>Conclusions: </strong>For patients with NSTE-ACS, our study showed seven clinical parameters to be associated with an increased risk of 6-month mortality. These included increasing age, increased heart rate, cardiac arrest at presentation, Killip class II-IV, diabetes, TIMI score of >4 and GRACE score of >150. Thereby aiding clinicians to apply strategic and precise interventions in monitoring these patients accordingly.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"286-292"},"PeriodicalIF":0.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/1f/sha-33-4-286.PMC8754448.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index. 非传统脂质参数对冠心病发展的影响:血浆致动脉粥样硬化指数、致动脉粥样硬化系数和脂蛋白综合指数。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-09-20 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1266
Ersin Çelik, Ahmet Rıfkı Çora, Kadir Burhan Karadem

Objective: In this study, we investigated the usability of atherogenic indices of patients who underwent coronary artery bypass surgery (CABG) due to coronary artery disease and patients without CAD as risk factors and markers for cardiovascular disease (CVD).

Methods: The data of 150 patients who underwent CABG, and 155 patients who underwent coronary angiography and was not diagnosed with CAD were analysed retrospectively. Demographic data and plasma lipid values were collected. The relationship between these ratios and CVD was investigated via univariate logistic regression analysis performed by creating atherogenic indices.

Results: The data of 125 patients who underwent CABG between May 2018 and May 2020 (90 males, 35 females; mean age 64,94 ± 9,61), and 155 patients who had coronary angiography between the same dates and found to have no CAD (64 males, 91 females; mean age 60,12 ± 11,6) were analysed retrospectively. The atherogenic index of plasma (AIP), atherogenic coefficient (AC) and lipoprotein combined index (LCI) ratios were found to be significantly higher in the CABG group compared to the control group (p < 0.001). CABG applied patients were divided into three groups according to their SYNTAX Score-I values. There was no statistical difference in the AIP (p = 0.434), AC (p = 0.715) and LCI (p = 0.891) ratios between the groups. In the ROC analysis of the CABG group, it was found that the AC value was the highest in terms of sensitivity with a value of 74.4% (AUC = 0.669, p < 0.001), and the LCI was the highest in terms of specificity with a value of 65.8% (AUC = 0.634, p < 0.001). In the univariate logistic regression analysis created, it was seen that all three indices had a significant effect in the CABG group (AIP; OR 0.493 p = 0,002, AC; OR 0.298 p < 0,001, LCI; OR 0.358 p = 0,001).

Conclusion: The use of atherogenic indices in daily practice can be recommended in the process of monitoring the risk of CVD in CAD patients, along with determining those patients' lipid profiles.

目的:在本研究中,我们调查了因冠状动脉疾病而接受冠状动脉搭桥术(CABG)的患者和无CAD的患者的动脉粥样硬化指数作为心血管疾病(CVD)的危险因素和标志物的可用性,并对155例经冠状动脉造影未诊断为冠心病的患者进行回顾性分析。收集人口统计学数据和血脂值。通过创建动脉粥样硬化指数进行单变量逻辑回归分析,研究这些比率与心血管疾病之间的关系。结果:回顾性分析了2018年5月至2020年5月期间接受冠状动脉搭桥术的125名患者(90名男性,35名女性;平均年龄64,94±9,61)和同期进行冠状动脉造影但未发现CAD的155名患者(64名男性,91名女性;平均年龄60,12±11,6)的数据。与对照组相比,CABG组的血浆动脉粥样硬化指数(AIP)、动脉粥样硬化系数(AC)和脂蛋白综合指数(LCI)比值显著升高(p<0.001)。应用CABG的患者根据其综合评分I值分为三组。两组之间的AIP(p=0.434)、AC(p=0.715)和LCI(p=0.891)比率没有统计学差异。在CABG组的ROC分析中,发现AC值的敏感性最高,为74.4%(AUC=0.669,p<0.001),LCI的特异性最高,为65.8%(AUC=0.0634,p<0.0001),这三个指标在CABG组中都有显著影响(AIP;OR 0.493 p=0002,AC;OR 0.298 p<0.001,LCI;OR 0.358 p=0001)。
{"title":"The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index.","authors":"Ersin Çelik,&nbsp;Ahmet Rıfkı Çora,&nbsp;Kadir Burhan Karadem","doi":"10.37616/2212-5043.1266","DOIUrl":"10.37616/2212-5043.1266","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we investigated the usability of atherogenic indices of patients who underwent coronary artery bypass surgery (CABG) due to coronary artery disease and patients without CAD as risk factors and markers for cardiovascular disease (CVD).</p><p><strong>Methods: </strong>The data of 150 patients who underwent CABG, and 155 patients who underwent coronary angiography and was not diagnosed with CAD were analysed retrospectively. Demographic data and plasma lipid values were collected. The relationship between these ratios and CVD was investigated via univariate logistic regression analysis performed by creating atherogenic indices.</p><p><strong>Results: </strong>The data of 125 patients who underwent CABG between May 2018 and May 2020 (90 males, 35 females; mean age 64,94 ± 9,61), and 155 patients who had coronary angiography between the same dates and found to have no CAD (64 males, 91 females; mean age 60,12 ± 11,6) were analysed retrospectively. The atherogenic index of plasma (AIP), atherogenic coefficient (AC) and lipoprotein combined index (LCI) ratios were found to be significantly higher in the CABG group compared to the control group (p < 0.001). CABG applied patients were divided into three groups according to their SYNTAX Score-I values. There was no statistical difference in the AIP (p = 0.434), AC (p = 0.715) and LCI (p = 0.891) ratios between the groups. In the ROC analysis of the CABG group, it was found that the AC value was the highest in terms of sensitivity with a value of 74.4% (AUC = 0.669, p < 0.001), and the LCI was the highest in terms of specificity with a value of 65.8% (AUC = 0.634, p < 0.001). In the univariate logistic regression analysis created, it was seen that all three indices had a significant effect in the CABG group (AIP; OR 0.493 p = 0,002, AC; OR 0.298 p < 0,001, LCI; OR 0.358 p = 0,001).</p><p><strong>Conclusion: </strong>The use of atherogenic indices in daily practice can be recommended in the process of monitoring the risk of CVD in CAD patients, along with determining those patients' lipid profiles.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 3","pages":"244-250"},"PeriodicalIF":0.8,"publicationDate":"2021-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7c/f3/sha-244-250.PMC8480409.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39505872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Sensitivity and Specificity of Pulmonary Artery Pressure Measurement in Echocardiography and Correlation with Right Heart Catheterization. 超声心动图肺动脉压测量的敏感性和特异性及其与右心导管置入的相关性。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-08-30 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1262
Muhammad Adil Soofi, Muhammad Azam Shah, Ammar Mohammed AlQadhi, Abdullah Mofareh AlAnazi, Waleed M Alshehri, Amir Umair

Objective: Echocardiography is helpful in assessment of pulmonary hemodynamic, however its correlation with Right heart catheterization (RHC) is conflicting. We conducted a study to evaluate sensitivity and specificity of pulmonary hemodynamic parameters measured in echocardiography. Furthermore its correlation with the values measured in RHC was assessed.

Method: Retrospective, cross-sectional study conducted at King Fahad medical City, Riyadh, Saudi Arabia. 95 adult patients referred for right heart catheterization were enrolled in the study. All the patients had echocardiography and RHC within one week of each other.

Result: Diabetes mellitus, hypertension and dyslipidemia were present among 55%, 66% and 41% of patients respectively. 85% of the study participants were diagnosed to have pulmonary hypertension and 79% of the study participants had postcapillary pulmonary hypertension. Sensitivity of pulmonary artery systolic pressure (PAPs), mean pulmonary artery pressure (PAPm) using PAPs and pulmonary artery acceleration velocity (PAcT) were 86%, 93% and 89% respectively. Correlation of PAPs, PAPm using PAPs and PAcT on echo with invasive hemodynamic in RHC were 0.56, 0.43 and 0.24 respectively. Among patients with moderate to severe Tricuspid Regurgitation (TR) and tricuspid annular plane systolic excursion (TAPSE) <1.5cm correlation of PAPs, PAPm using PAPs and PAcT on echocardiography with right heart catheterization were 0.31, 0.24 and 0.42 respectively.

Conclusion: Echocardiographic assessment of PAPs and PAPm has high sensitivity and weak to moderate correlation with hemodynamic data in RHC. PAPs measurement on echocardiogram has best correlation with invasive measurement followed by PAPm measurement using PAPs. Among patients with moderate to severe TR and TAPSE <1.5cm PAPm measurement using PAcT has better correlation than using PAPs.

目的:超声心动图有助于评估肺血流动力学,但其与右心导管(RHC)的相关性存在矛盾。我们进行了一项研究,以评估超声心动图测量肺血流动力学参数的敏感性和特异性。进一步评价其与RHC测量值的相关性。方法:在沙特阿拉伯利雅得法赫德国王医疗城进行回顾性横断面研究,纳入95例转诊右心导管的成年患者。所有患者均在一周内进行超声心动图和RHC检查。结果:糖尿病占55%,高血压占66%,血脂异常占41%。85%的研究参与者被诊断患有肺动脉高压,79%的研究参与者患有毛细血管后肺动脉高压。肺动脉收缩压(PAPs)、平均肺动脉压(PAPm)和肺动脉加速速度(PAcT)的敏感性分别为86%、93%和89%。PAPs、PAPm及超声PAcT与RHC有创血流动力学的相关性分别为0.56、0.43、0.24。结论:超声心动图评价三尖瓣反流(TR)和三尖瓣环面收缩偏移(TAPSE)与RHC血流动力学数据具有高敏感性和弱至中度相关性。超声心动图上的PAPs测量与有创测量的相关性最好,随后使用PAPs测量PAPm。在中重度TR和TAPSE患者中
{"title":"Sensitivity and Specificity of Pulmonary Artery Pressure Measurement in Echocardiography and Correlation with Right Heart Catheterization.","authors":"Muhammad Adil Soofi,&nbsp;Muhammad Azam Shah,&nbsp;Ammar Mohammed AlQadhi,&nbsp;Abdullah Mofareh AlAnazi,&nbsp;Waleed M Alshehri,&nbsp;Amir Umair","doi":"10.37616/2212-5043.1262","DOIUrl":"https://doi.org/10.37616/2212-5043.1262","url":null,"abstract":"<p><strong>Objective: </strong>Echocardiography is helpful in assessment of pulmonary hemodynamic, however its correlation with Right heart catheterization (RHC) is conflicting. We conducted a study to evaluate sensitivity and specificity of pulmonary hemodynamic parameters measured in echocardiography. Furthermore its correlation with the values measured in RHC was assessed.</p><p><strong>Method: </strong>Retrospective, cross-sectional study conducted at King Fahad medical City, Riyadh, Saudi Arabia. 95 adult patients referred for right heart catheterization were enrolled in the study. All the patients had echocardiography and RHC within one week of each other.</p><p><strong>Result: </strong>Diabetes mellitus, hypertension and dyslipidemia were present among 55%, 66% and 41% of patients respectively. 85% of the study participants were diagnosed to have pulmonary hypertension and 79% of the study participants had postcapillary pulmonary hypertension. Sensitivity of pulmonary artery systolic pressure (PAPs), mean pulmonary artery pressure (PAPm) using PAPs and pulmonary artery acceleration velocity (PAcT) were 86%, 93% and 89% respectively. Correlation of PAPs, PAPm using PAPs and PAcT on echo with invasive hemodynamic in RHC were 0.56, 0.43 and 0.24 respectively. Among patients with moderate to severe Tricuspid Regurgitation (TR) and tricuspid annular plane systolic excursion (TAPSE) <1.5cm correlation of PAPs, PAPm using PAPs and PAcT on echocardiography with right heart catheterization were 0.31, 0.24 and 0.42 respectively.</p><p><strong>Conclusion: </strong>Echocardiographic assessment of PAPs and PAPm has high sensitivity and weak to moderate correlation with hemodynamic data in RHC. PAPs measurement on echocardiogram has best correlation with invasive measurement followed by PAPm measurement using PAPs. Among patients with moderate to severe TR and TAPSE <1.5cm PAPm measurement using PAcT has better correlation than using PAPs.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 3","pages":"228-236"},"PeriodicalIF":0.8,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/fe/sha-228-236.PMC8439191.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39475502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Levels of Evidence within Cardiovascular Medicine Research in Saudi Arabia: A Systematic Review. 沙特阿拉伯心血管医学研究的证据水平:系统回顾。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-08-16 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1264
Sultan Alotaibi, Alexandra M Schuster, Bernardo Perez-Villa, Jaime Hernandez-Montfort

International commitments to reduce the prevalence of non-communicable disease have led the Government of Saudi Arabia to invest more in research related to cardiovascular disease. However, the strength of evidence derived from these research activities remains unclear. The aim of our study was to examine the level of evidence within clinical Cardiovascular Medicine research in Saudi Arabia. We conducted a systematic review of published articles that included a population from Saudi Arabia. Electronic databases EMBASE and MEDLINE (Ovid) were searched up to 25th of April 2021, supplemented by a second search in CENTRAL (Cochrane Central Register of Controlled Trials) and www.clinicaltrials.gov. In addition, the Snowball- and Pearl-growing methods of search were conducted for finding additional eligible articles. Finally, a search was conducted in PubMed database for all eligible articles published by Journal of the Saudi Heart Association from the first indexed issue up to April 2021. Level of evidence of reviewed articles was determined using the Oxford Level of Evidence 2 scale. We calculated the mean level of evidence over 5-year periods, and explored evidence for a time trend for number of published articles and LOE using linear regression. Of the 1113 records identified, 418 met the inclusion criteria for analysis. The articles were published between September 1986 and March 2021. More than half of the included articles were level IV studies (n = 242, 57.8%). Furthermore, we observed no trend over the years for increased mean of level of evidence (β = -0.07, 95% CI [-0.20, -0.06], p = 0.236). Overall, the level of evidence produced by the articles in clinical Cardiovascular Medicine in Saudi Arabia is very low. Prioritizing higher-quality research is critical to produce the clinical practices and policies necessary to reduce the burden of cardiovascular diseases in Saudi Arabia.

减少非传染性疾病发病率的国际承诺促使沙特阿拉伯政府加大了对心血管疾病研究的投入。然而,从这些研究活动中获得的证据的力度仍不明确。我们的研究旨在考察沙特阿拉伯临床心血管医学研究的证据水平。我们对包含沙特阿拉伯人口的已发表文章进行了系统性回顾。我们检索了截至 2021 年 4 月 25 日的电子数据库 EMBASE 和 MEDLINE(Ovid),并在 CENTRAL(Cochrane Central Register of Controlled Trials)和 www.clinicaltrials.gov 中进行了二次检索。此外,还采用了 "雪球 "和 "珍珠 "检索方法,以寻找更多符合条件的文章。最后,在 PubMed 数据库中检索了《沙特心脏协会杂志》从第一期索引到 2021 年 4 月发表的所有符合条件的文章。采用牛津证据等级2量表确定受审文章的证据等级。我们计算了5年期间的平均证据水平,并使用线性回归法探究了发表文章数量和LOE的时间趋势证据。在确定的 1113 条记录中,有 418 条符合纳入分析的标准。这些文章发表于 1986 年 9 月至 2021 年 3 月之间。一半以上的纳入文章为 IV 级研究(n = 242,57.8%)。此外,我们没有观察到证据等级平均值逐年上升的趋势(β = -0.07,95% CI [-0.20, -0.06],p = 0.236)。总体而言,沙特阿拉伯临床心血管医学论文的证据水平很低。优先考虑更高质量的研究对于制定减少沙特阿拉伯心血管疾病负担所需的临床实践和政策至关重要。
{"title":"Levels of Evidence within Cardiovascular Medicine Research in Saudi Arabia: A Systematic Review.","authors":"Sultan Alotaibi, Alexandra M Schuster, Bernardo Perez-Villa, Jaime Hernandez-Montfort","doi":"10.37616/2212-5043.1264","DOIUrl":"10.37616/2212-5043.1264","url":null,"abstract":"<p><p>International commitments to reduce the prevalence of non-communicable disease have led the Government of Saudi Arabia to invest more in research related to cardiovascular disease. However, the strength of evidence derived from these research activities remains unclear. The aim of our study was to examine the level of evidence within clinical Cardiovascular Medicine research in Saudi Arabia. We conducted a systematic review of published articles that included a population from Saudi Arabia. Electronic databases EMBASE and MEDLINE (Ovid) were searched up to 25<sup>th</sup> of April 2021, supplemented by a second search in CENTRAL (Cochrane Central Register of Controlled Trials) and www.clinicaltrials.gov. In addition, the Snowball- and Pearl-growing methods of search were conducted for finding additional eligible articles. Finally, a search was conducted in PubMed database for all eligible articles published by Journal of the Saudi Heart Association from the first indexed issue up to April 2021. Level of evidence of reviewed articles was determined using the Oxford Level of Evidence 2 scale. We calculated the mean level of evidence over 5-year periods, and explored evidence for a time trend for number of published articles and LOE using linear regression. Of the 1113 records identified, 418 met the inclusion criteria for analysis. The articles were published between September 1986 and March 2021. More than half of the included articles were level IV studies (n = 242, 57.8%). Furthermore, we observed no trend over the years for increased mean of level of evidence (β = -0.07, 95% CI [-0.20, -0.06], p = 0.236). Overall, the level of evidence produced by the articles in clinical Cardiovascular Medicine in Saudi Arabia is very low. Prioritizing higher-quality research is critical to produce the clinical practices and policies necessary to reduce the burden of cardiovascular diseases in Saudi Arabia.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 3","pages":"237-243"},"PeriodicalIF":0.7,"publicationDate":"2021-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/93/e0/sha-237-243.PMC8425340.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39475503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brucella Prosthetic Valve Endocarditis: A Systematic Review. 布氏菌人工瓣膜心内膜炎:系统综述。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-08-09 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1257
Karima Taamallah, Fatma Hammami, Hédi Gharsallah, Makram Koubaa, Mounir Ben Jemaa, Wafa Fehri

Objective: Brucella prosthetic valve endocarditis is a rare but a life-threatening complication of brucellosis. It remains a diagnostic challenge. Optimal treatment of Brucella prosthetic valve endocarditis is debated. Available data is limited to case reports or small case series. The purpose of this study was to systematically review all published cases of Brucella prosthetic valve endocarditis in the literature.

Method: A systematic review of PubMed database, Google, Google Scholar, and Scopus (From January 1974 to the present) for studies providing epidemiological, clinical and microbiological data as well as data on treatment and outcomes of Brucella prosthetic valve endocarditis was performed.

Results: A total of 51 reported cases were reviewed. Brucella melitensis (45%) and Brucella abortus (11.7%) were the most frequently isolated species. Most common type of prosthesis valve was mechanical prothesis (84.3%) and ten patients had double valve prosthesis (19.6%). Fever and dyspnea were present in 100% and 37.2% of the cases, respectively. The diagnosis was set with echocardiographic finding in 30 cases (93.7%), which revealed vegetation in 27 cases (84.3%). Most used antibiotics were rifampicin, doxycycline and aminoglycoside or cotrimoxazole. No deaths were noted in patients treated by combined medical and surgical treatment, but mortality was noted in 27.7% of the cases treated by antibiotics alone (p = 0.006).

Conclusion: This systematic review highlights diagnostic challenges and demonstrates that surgery improved outcome by reducing mortality in patients treated with the combined surgical and medical treatment option. Brucellosis should be considered in the differential diagnosis of prosthetic valve endocarditis in patients residing in or traveling to areas of endemicity.

目的:布鲁氏菌人工瓣膜心内膜炎是一种罕见但危及生命的布鲁氏菌病并发症。这仍然是一个诊断上的挑战。布氏菌人工瓣膜心内膜炎的最佳治疗方法一直存在争议。可用的数据仅限于病例报告或小病例系列。本研究的目的是系统地回顾文献中所有已发表的布鲁氏菌人工瓣膜心内膜炎病例。方法:系统回顾PubMed数据库、Google、Google Scholar和Scopus数据库(1974年1月至今)中关于布鲁氏菌人工瓣膜心内膜炎的流行病学、临床和微生物学资料以及治疗和结局的研究。结果:共回顾了51例报告病例。最常见的分离种为melitensis布鲁氏菌(45%)和abortus布鲁氏菌(11.7%)。机械瓣膜类型最多(84.3%),双瓣膜类型10例(19.6%)。发热和呼吸困难分别占100%和37.2%。超声心动图诊断30例(93.7%),显示植被27例(84.3%)。使用最多的抗生素是利福平、强力霉素、氨基糖苷或复方新诺明。内科和外科联合治疗的患者无死亡,但单独使用抗生素治疗的患者有27.7%的死亡率(p = 0.006)。结论:本系统综述强调了诊断方面的挑战,并证明手术通过降低手术和药物联合治疗方案患者的死亡率来改善预后。布鲁氏菌病应考虑在鉴别诊断假瓣膜心内膜炎患者居住或旅行到地方性地区。
{"title":"<i>Brucella</i> Prosthetic Valve Endocarditis: A Systematic Review.","authors":"Karima Taamallah,&nbsp;Fatma Hammami,&nbsp;Hédi Gharsallah,&nbsp;Makram Koubaa,&nbsp;Mounir Ben Jemaa,&nbsp;Wafa Fehri","doi":"10.37616/2212-5043.1257","DOIUrl":"https://doi.org/10.37616/2212-5043.1257","url":null,"abstract":"<p><strong>Objective: </strong><i>Brucella</i> prosthetic valve endocarditis is a rare but a life-threatening complication of brucellosis. It remains a diagnostic challenge. Optimal treatment of <i>Brucella</i> prosthetic valve endocarditis is debated. Available data is limited to case reports or small case series. The purpose of this study was to systematically review all published cases of <i>Brucella</i> prosthetic valve endocarditis in the literature.</p><p><strong>Method: </strong>A systematic review of PubMed database, Google, Google Scholar, and Scopus (From January 1974 to the present) for studies providing epidemiological, clinical and microbiological data as well as data on treatment and outcomes of <i>Brucella</i> prosthetic valve endocarditis was performed.</p><p><strong>Results: </strong>A total of 51 reported cases were reviewed. <i>Brucella melitensis</i> (45%) and <i>Brucella abortus</i> (11.7%) were the most frequently isolated species. Most common type of prosthesis valve was mechanical prothesis (84.3%) and ten patients had double valve prosthesis (19.6%). Fever and dyspnea were present in 100% and 37.2% of the cases, respectively. The diagnosis was set with echocardiographic finding in 30 cases (93.7%), which revealed vegetation in 27 cases (84.3%). Most used antibiotics were rifampicin, doxycycline and aminoglycoside or cotrimoxazole. No deaths were noted in patients treated by combined medical and surgical treatment, but mortality was noted in 27.7% of the cases treated by antibiotics alone (p = 0.006).</p><p><strong>Conclusion: </strong>This systematic review highlights diagnostic challenges and demonstrates that surgery improved outcome by reducing mortality in patients treated with the combined surgical and medical treatment option. Brucellosis should be considered in the differential diagnosis of prosthetic valve endocarditis in patients residing in or traveling to areas of endemicity.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 3","pages":"198-212"},"PeriodicalIF":0.8,"publicationDate":"2021-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bd/41/sha-198-212.PMC8366765.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Heart Involvement in a Moroccan Population with Spondyloarthritis: A Cross-sectional Study. 摩洛哥脊柱关节炎患者的心脏受累情况:横断面研究
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-07-08 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1258
Jalila Eddarami, Hamida Azzouzi, Linda Ichchou

Objectives: The aim of this study was to investigate the prevalence of cardiac manifestations and their predictive factors in Moroccan patients with spondyloarthritis (SpA).

Methods: We have conducted a cross-sectional study over four months at the Department of Rheumatology in Mohammed VI University Hospital of Oujda, Morocco. All SpA patients fulfilled the 2009 Assessment SpondyloArthritis international Society (ASAS) criteria. Every patient had a cardiac check up including clinical examination, 12-lead electrocardiogram (ECG) and transthoracic echocardiography (TTE). Multiple logistic regression was used to analyze the associated factors with cardiac manifestations.

Results: We included 64 men and 30 women with a mean age of 37.32 ± 12.65 years old. The mean disease duration was 10.60 ± 7.61 years. Patients had a mean Ankylosing Spondylitis Disease Activity Score (ASDAS) CRP of 2.25 ± 1.38, a mean Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) of 2.88 ± 2.26 and a mean Bath Ankylosing Spondylitis Functional Index (BASFI) of 33.52 ± 30.49. Traditional cardiovascular risk factors (CVRF) included dyslipidemia in 14.9%, hypertension in 9.6% and type 2 diabetes in 7.4% of the cases. Eight patients (8.5%) smoked and 3 patients (3.2%) used alcohol whereas 20 patients (21.3%) had a history of smoking and 5 patients (6.3%) a history of alcohol. Cardiac manifestations were found in 12 patients (13.3%): 3.3% had aortic regurgitation (AR), 1.1% had aortic dilatation, 1.1% had aortic valve thickening (AVT), 2.2% had mitral thickening, 1.1% had mitral regurgitation (MR), 1.1% had mitral stenosis (MS), 3.3 had pericarditis and 2.2% had complete right bundle branch block (RBBB). In multivariate analysis, cardiac involvement was significantly associated with extra-articular manifestations (OR = 6.05; 95% CI: 1.197-30.607, p = 0.029).

Conclusion: Based on these results, cardiac involvement was common and associated with the severity of the disease; hence, early detection of cardiac abnormalities and targeted treatment strategies of SpA and comorbidities are necessary to control the systemic inflammation and improve the excess of cardiovascular mortality in this group of patients.

研究目的本研究旨在调查摩洛哥脊柱关节炎(SpA)患者的心脏表现及其预测因素:我们在摩洛哥乌季达穆罕默德六世大学医院风湿科进行了为期四个月的横断面研究。所有 SpA 患者均符合 2009 年国际脊柱关节炎协会(ASAS)的评估标准。每位患者都接受了心脏检查,包括临床检查、12导联心电图(ECG)和经胸超声心动图(TTE)。采用多元逻辑回归分析与心脏表现相关的因素:男性 64 人,女性 30 人,平均年龄(37.32±12.65)岁。平均病程为(10.60 ± 7.61)年。患者的平均强直性脊柱炎疾病活动评分(ASDAS)CRP为(2.25 ± 1.38),平均巴氏强直性脊柱炎疾病活动指数(BASDAI)为(2.88 ± 2.26),平均巴氏强直性脊柱炎功能指数(BASFI)为(33.52 ± 30.49)。传统的心血管风险因素(CVRF)包括血脂异常(14.9%)、高血压(9.6%)和 2 型糖尿病(7.4%)。8名患者(8.5%)吸烟,3名患者(3.2%)酗酒,而20名患者(21.3%)有吸烟史,5名患者(6.3%)有酗酒史。12名患者(13.3%)有心脏表现:3.3%有主动脉瓣反流(AR),1.1%有主动脉瓣扩张,1.1%有主动脉瓣增厚(AVT),2.2%有二尖瓣增厚,1.1%有二尖瓣反流(MR),1.1%有二尖瓣狭窄(MS),3.3%有心包炎,2.2%有完全性右束支传导阻滞(RBBB)。在多变量分析中,心脏受累与关节外表现显著相关(OR = 6.05; 95% CI: 1.197-30.607, p = 0.029):基于这些结果,心脏受累很常见,且与疾病的严重程度有关;因此,有必要及早发现心脏异常,并针对 SpA 和合并症采取有针对性的治疗策略,以控制全身炎症,改善这类患者心血管疾病死亡率过高的问题。
{"title":"Heart Involvement in a Moroccan Population with Spondyloarthritis: A Cross-sectional Study.","authors":"Jalila Eddarami, Hamida Azzouzi, Linda Ichchou","doi":"10.37616/2212-5043.1258","DOIUrl":"10.37616/2212-5043.1258","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to investigate the prevalence of cardiac manifestations and their predictive factors in Moroccan patients with spondyloarthritis (SpA).</p><p><strong>Methods: </strong>We have conducted a cross-sectional study over four months at the Department of Rheumatology in Mohammed VI University Hospital of Oujda, Morocco. All SpA patients fulfilled the 2009 Assessment SpondyloArthritis international Society (ASAS) criteria. Every patient had a cardiac check up including clinical examination, 12-lead electrocardiogram (ECG) and transthoracic echocardiography (TTE). Multiple logistic regression was used to analyze the associated factors with cardiac manifestations.</p><p><strong>Results: </strong>We included 64 men and 30 women with a mean age of 37.32 ± 12.65 years old. The mean disease duration was 10.60 ± 7.61 years. Patients had a mean Ankylosing Spondylitis Disease Activity Score (ASDAS) CRP of 2.25 ± 1.38, a mean Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) of 2.88 ± 2.26 and a mean Bath Ankylosing Spondylitis Functional Index (BASFI) of 33.52 ± 30.49. Traditional cardiovascular risk factors (CVRF) included dyslipidemia in 14.9%, hypertension in 9.6% and type 2 diabetes in 7.4% of the cases. Eight patients (8.5%) smoked and 3 patients (3.2%) used alcohol whereas 20 patients (21.3%) had a history of smoking and 5 patients (6.3%) a history of alcohol. Cardiac manifestations were found in 12 patients (13.3%): 3.3% had aortic regurgitation (AR), 1.1% had aortic dilatation, 1.1% had aortic valve thickening (AVT), 2.2% had mitral thickening, 1.1% had mitral regurgitation (MR), 1.1% had mitral stenosis (MS), 3.3 had pericarditis and 2.2% had complete right bundle branch block (RBBB). In multivariate analysis, cardiac involvement was significantly associated with extra-articular manifestations (OR = 6.05; 95% CI: 1.197-30.607, p = 0.029).</p><p><strong>Conclusion: </strong>Based on these results, cardiac involvement was common and associated with the severity of the disease; hence, early detection of cardiac abnormalities and targeted treatment strategies of SpA and comorbidities are necessary to control the systemic inflammation and improve the excess of cardiovascular mortality in this group of patients.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 2","pages":"191-197"},"PeriodicalIF":0.7,"publicationDate":"2021-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/29/bc/sha-149.PMC8294134.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39221758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Unusual Intracoronary Honeycomb Pattern in a Patient with Coronary Artery Disease with Dextrocardia. 冠心病伴右心的冠状动脉内不寻常的蜂窝状模式。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-07-07 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1254
Ajay P Singh, Ajay Raj, Kaushal Chaudhary, Ranjit K Nath

This case highlights the diagnostic dilemma and emphasis the role of Optical Coherence Tomography (OCT) to differentiate between spontaneous coronary artery dissection and recanalized thrombus with multiple channels in a patient with dextrocardia.

本病例强调了诊断困境,并强调了光学相干断层扫描(OCT)在区分右心患者自发性冠状动脉夹层和多通道再通血栓中的作用。
{"title":"An Unusual Intracoronary Honeycomb Pattern in a Patient with Coronary Artery Disease with Dextrocardia.","authors":"Ajay P Singh,&nbsp;Ajay Raj,&nbsp;Kaushal Chaudhary,&nbsp;Ranjit K Nath","doi":"10.37616/2212-5043.1254","DOIUrl":"https://doi.org/10.37616/2212-5043.1254","url":null,"abstract":"<p><p>This case highlights the diagnostic dilemma and emphasis the role of Optical Coherence Tomography (OCT) to differentiate between spontaneous coronary artery dissection and recanalized thrombus with multiple channels in a patient with dextrocardia.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 2","pages":"186-190"},"PeriodicalIF":0.8,"publicationDate":"2021-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/98/sha186.PMC8274694.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39204491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal Membrane Oxygenation Used in Acute Respiratory Distress Syndrome with COVID-19: A Systematic Review and Meta-Analysis. 体外膜氧合治疗COVID-19急性呼吸窘迫综合征:系统回顾和荟萃分析
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-07-02 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1261
Novia Kusumawardhani, Ivana Purnama Dewi, Budi Baktijasa Dharmadjati

Introduction: Protective pulmonary mechanical ventilation, higher positive end-expiratory pressure, neuromuscular blockade, prone positioning, and pulmonary recruitment procedures are all strategies in severe COVID-19 cases. Extracorporeal Membrane Oxygenation (ECMO) can be seen as an alternative to traditional treatment in certain patients when conventional therapy fails. We present a study that intends to systematically review and meta-analysis ECMO use in COVID-19 patients.

Methods: We search major medical databases (Cochrane Library, PubMed, EMBASE, MedRxiv) for clinical trials that were released between January 2020 until February 2021, had full-text availability, were written in English, and humans studies.We used National Heart, Lung, and Blood Institute (NHLBI) quality evaluation methods for retrospective cohort and cross-sectional studies to evaluate the quality of the articles. In addition, we used the Mantel-Haenszel random-effects meta-analysis of using RevMan 5.4.

Results: A total of 33 studies involving 3090 patients were included in the systematic review and six studies in the meta-analysis. There were 828 patients admitted to the ICU, of which 779 patients had ARDS (94%). Of the total study, 527 patients received ECMO therapy (17%). ARDS incidence was associated with complications during ICU care compared to non-ICU care (OR 107.98; 95% CI 55.51-210.03; p < 0.00001). Indirect comparisons, the incidence of mortality was associated with ECMO compared with non-ECMO (OR 15.79; 95% CI 4.21-59.28; p < 0.0001).

Conclusion: The incidence of ARDS was associated with complications during ICU stay, and the incidence of mortality was associated with ECMO. Further study about mechanisms involving illness and death of patients from COVID-19 is needed.

导论:保护性肺机械通气、呼气末正压增高、神经肌肉阻滞、俯卧位和肺复盖术都是应对COVID-19重症病例的策略。体外膜氧合(ECMO)可以被视为传统治疗的替代方案,当某些患者的传统治疗失败。我们提出了一项旨在系统回顾和荟萃分析COVID-19患者使用ECMO的研究。方法:我们检索了主要的医学数据库(Cochrane Library、PubMed、EMBASE、MedRxiv),检索了在2020年1月至2021年2月期间发布的临床试验,这些临床试验具有全文可用性,以英文撰写,并进行了人体研究。我们采用国家心肺血液研究所(NHLBI)回顾性队列和横断面研究的质量评价方法来评价文章的质量。此外,我们使用RevMan 5.4进行了Mantel-Haenszel随机效应荟萃分析。结果:系统评价共纳入33项研究,共纳入3090例患者,meta分析纳入6项研究。ICU共收治828例患者,其中发生ARDS 779例(94%)。在整个研究中,527例患者接受了ECMO治疗(17%)。与非ICU护理相比,ICU护理期间ARDS发生率与并发症相关(OR 107.98;95% ci 55.51-210.03;P < 0.00001)。间接比较,与非ECMO相比,ECMO与死亡率发生率相关(OR 15.79;95% ci 4.21-59.28;P < 0.0001)。结论:ICU住院期间ARDS的发生率与并发症相关,ECMO的死亡率与ARDS的发生率相关。需要进一步研究COVID-19患者患病和死亡的机制。
{"title":"Extracorporeal Membrane Oxygenation Used in Acute Respiratory Distress Syndrome with COVID-19: A Systematic Review and Meta-Analysis.","authors":"Novia Kusumawardhani,&nbsp;Ivana Purnama Dewi,&nbsp;Budi Baktijasa Dharmadjati","doi":"10.37616/2212-5043.1261","DOIUrl":"https://doi.org/10.37616/2212-5043.1261","url":null,"abstract":"<p><strong>Introduction: </strong>Protective pulmonary mechanical ventilation, higher positive end-expiratory pressure, neuromuscular blockade, prone positioning, and pulmonary recruitment procedures are all strategies in severe COVID-19 cases. Extracorporeal Membrane Oxygenation (ECMO) can be seen as an alternative to traditional treatment in certain patients when conventional therapy fails. We present a study that intends to systematically review and meta-analysis ECMO use in COVID-19 patients.</p><p><strong>Methods: </strong>We search major medical databases (Cochrane Library, PubMed, EMBASE, MedRxiv) for clinical trials that were released between January 2020 until February 2021, had full-text availability, were written in English, and humans studies.We used National Heart, Lung, and Blood Institute (NHLBI) quality evaluation methods for retrospective cohort and cross-sectional studies to evaluate the quality of the articles. In addition, we used the Mantel-Haenszel random-effects meta-analysis of using RevMan 5.4.</p><p><strong>Results: </strong>A total of 33 studies involving 3090 patients were included in the systematic review and six studies in the meta-analysis. There were 828 patients admitted to the ICU, of which 779 patients had ARDS (94%). Of the total study, 527 patients received ECMO therapy (17%). ARDS incidence was associated with complications during ICU care compared to non-ICU care (OR 107.98; 95% CI 55.51-210.03; p < 0.00001). Indirect comparisons, the incidence of mortality was associated with ECMO compared with non-ECMO (OR 15.79; 95% CI 4.21-59.28; p < 0.0001).</p><p><strong>Conclusion: </strong>The incidence of ARDS was associated with complications during ICU stay, and the incidence of mortality was associated with ECMO. Further study about mechanisms involving illness and death of patients from COVID-19 is needed.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 2","pages":"177-185"},"PeriodicalIF":0.8,"publicationDate":"2021-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bb/ef/sha-177.PMC8294133.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39220846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of the Saudi Heart Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1